{"symbol": "CLSN", "companyName": "Celsion Corporation", "exchange": "NASDAQ Capital Market", "industry": "Biotechnology", "website": "http://www.celsion.com", "description": "Celsion Corp is a fully-integrated oncology drug development company. It is engaged in developing a portfolio of cancer treatments, including directed chemotherapies, immunotherapies and RNA- or DNA-based therapies.", "CEO": "Michael H. Tardugno", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}